Pharmeasy has determined the Conversion Price of the CCPS Series-A
Written by: Diksha Kalra
Published: Sep 16, 2026
Updated: Sep 16, 2026
1 min read
The company has determined the CCPS Series-A Conversion Price in accordance with the terms and conditions mentioned in a resolution passed by the Board meeting dated May 15, 2023, at ₹ 4.356 per share, which corresponds to a maximum of up to 125,88,32,279 equity shares to be issued upon the conversion of CCPS-A.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
